Lars Hansen

708 total citations
11 papers, 542 citations indexed

About

Lars Hansen is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Lars Hansen has authored 11 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Lars Hansen's work include Pancreatic function and diabetes (7 papers), Diabetes Treatment and Management (7 papers) and Metabolism, Diabetes, and Cancer (5 papers). Lars Hansen is often cited by papers focused on Pancreatic function and diabetes (7 papers), Diabetes Treatment and Management (7 papers) and Metabolism, Diabetes, and Cancer (5 papers). Lars Hansen collaborates with scholars based in Denmark, United States and United Kingdom. Lars Hansen's co-authors include Erica Nishimura, Niels Abrahamsen, Oluf Pedersen, Torben Hansen, Søren M. Echwald, Knut Borch‐Johnsen, Thomas Drivsholm, Eva-Maria D. Nielsen, Birger Thorsteinsson and Bendix Carstensen and has published in prestigious journals such as Diabetes, American Journal of Physiology-Cell Physiology and Peptides.

In The Last Decade

Lars Hansen

11 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Hansen Denmark 9 326 284 277 171 69 11 542
Jan Lynge Denmark 6 184 0.6× 197 0.7× 346 1.2× 96 0.6× 94 1.4× 6 547
James S. McTaggart United Kingdom 7 164 0.5× 306 1.1× 120 0.4× 190 1.1× 84 1.2× 9 588
Hedvig Bennet Sweden 11 297 0.9× 206 0.7× 175 0.6× 193 1.1× 70 1.0× 15 546
Ajin Lim South Korea 9 189 0.6× 258 0.9× 90 0.3× 54 0.3× 141 2.0× 11 502
Parvaneh Keshavarz Iran 11 107 0.3× 163 0.6× 83 0.3× 103 0.6× 41 0.6× 38 361
Yoshitaka Yasuhara Japan 9 159 0.5× 165 0.6× 136 0.5× 30 0.2× 63 0.9× 11 382
Charlotte Kane United Kingdom 6 234 0.7× 201 0.7× 234 0.8× 37 0.2× 28 0.4× 8 504
Osamu Kikuchi Japan 12 254 0.8× 272 1.0× 137 0.5× 69 0.4× 118 1.7× 19 507
Holly E. Bates Canada 10 195 0.6× 160 0.6× 207 0.7× 81 0.5× 192 2.8× 15 554
Jean-Claude Chèvre France 9 549 1.7× 336 1.2× 251 0.9× 443 2.6× 42 0.6× 12 706

Countries citing papers authored by Lars Hansen

Since Specialization
Citations

This map shows the geographic impact of Lars Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Hansen more than expected).

Fields of papers citing papers by Lars Hansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Hansen. The network helps show where Lars Hansen may publish in the future.

Co-authorship network of co-authors of Lars Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Hansen. A scholar is included among the top collaborators of Lars Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Hansen. Lars Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
3.
Dandona, Paresh, Chantal Mathieu, Moshe Phillip, et al.. (2019). 1231-P: Dapagliflozin (DAPA) in Type 1 Diabetes (T1D): Pooled Outcomes from DEPICT-1 and -2. Diabetes. 68(Supplement_1). 2 indexed citations
4.
Larger, Étienne, Nicolai J. Wewer Albrechtsen, Lars Hansen, et al.. (2016). Pancreatic α-cell hyperplasia and hyperglucagonemia due to a glucagon receptor splice mutation. Endocrinology Diabetes and Metabolism Case Reports. 2016. 37 indexed citations
5.
Nielsen, Eva-Maria D., Lars Hansen, Søren M. Echwald, et al.. (2003). Evidence for an association between the Leu162Val polymorphism of the PPARalpha gene and decreased fasting serum triglyceride levels in glucose tolerant subjects.. PubMed. 13(7). 417–23. 18 indexed citations
6.
Nielsen, Eva-Maria D., Lars Hansen, Bendix Carstensen, et al.. (2003). The E23K Variant of Kir6.2 Associates With Impaired Post-OGTT Serum Insulin Response and Increased Risk of Type 2 Diabetes. Diabetes. 52(2). 573–577. 211 indexed citations
7.
Nielsen, Eva-Maria D., Lars Hansen, Søren M. Echwald, et al.. (2003). . Pharmacogenetics. 13(7). 417–423. 15 indexed citations
8.
Hansen, Lars, et al.. (1998). Glucagon-mediated Ca2+signaling in BHK cells expressing cloned human glucagon receptors. American Journal of Physiology-Cell Physiology. 274(6). C1552–C1562. 47 indexed citations
10.
Hansen, Lars, Niels Abrahamsen, Jörg Hager, et al.. (1996). The Gly40Ser Mutation in the Human Glucagon Receptor Gene Associated With NIDDM Results in a Receptor With Reduced Sensitivity to Glucagon. Diabetes. 45(6). 725–730. 33 indexed citations
11.
Hansen, Lars, Niels Abrahamsen, & Erica Nishimura. (1995). Glucagon receptor mRNA distribution in rat tissues. Peptides. 16(6). 1163–1166. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026